DANIELLE MARTIN: Open Payments
NPI 1023697828 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 29 payments from 18 companies in 2025. Trend: 2023 $188 · 2024 $374 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Amgen Inc. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Insulet Corporation | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: TRELEGY ELLIPTA, Kerendia, AIRSUPRA, XIFAXAN, EVENITY, Omnipod, Belbuca, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
